ArticleJournal of hematology & oncology2022

Pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) prevents severe SARS-CoV-2 infection in recipients of allogeneic hematopoietic stem cell transplantation during the Omicron wave: a multicentric retrospective study of SFGM-TC.

Ludovic Jondreville et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.